Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine in Chronic Myelomonocytic Leukemia
NCT01098084Phase 2Completed
- Sponsor
- Groupe Français des Myélodysplasies
- Start
- Nov 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in chronic myelomonocytic leukemia (CMML), sponsored by Groupe Français des Myélodysplasies. Started Nov 2008; status: completed.
02
Drugs
decitabine
03
Conditions
chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT01098084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098084.